Subtopic Deep Dive

Drug-Induced Gingival Overgrowth
Research Guide

What is Drug-Induced Gingival Overgrowth?

Drug-Induced Gingival Overgrowth (DIGO) is gingival hyperplasia caused by medications including phenytoin, cyclosporin A, and calcium channel blockers in chronically medicated patients.

DIGO affects transplant patients and those on anticonvulsants, leading to excessive gingival tissue growth impairing oral hygiene and aesthetics. Key studies identify prevalence up to 50% in cyclosporin users and risk factors like poor plaque control (Seymour et al., 2000, 309 citations; Seymour et al., 1996, 400 citations). Over 10 papers in the provided list address pathogenesis, risks, and management, with foundational works from 1991-2006.

Curated Papers

Key Challenges

Why It Matters

DIGO complicates oral health in 30-80% of organ transplant recipients on cyclosporin, requiring surgical interventions and increasing periodontitis risk (Seymour et al., 1996). It elevates treatment costs and impacts quality of life in epileptic patients on phenytoin (Hassell and Hefti, 1991). Matrix metalloproteinase dysregulation links DIGO to broader periodontal destruction, informing therapies like doxycycline adjuncts (Sorsa et al., 2006). Risk factor analysis guides preventive protocols in clinical practice (Seymour et al., 2000).

Key Research Challenges

Unclear Pathogenesis Mechanisms

No unifying hypothesis explains DIGO from phenytoin, cyclosporin, or calcium blockers despite fibroblast hyperactivity (Seymour et al., 1996). Conflicting roles of inflammation and drug metabolism persist. Over 400 citations highlight persistent gaps in cellular pathways.

Identifying Precise Risk Factors

Plaque index, drug dosage, and duration predict severity, but patient genetics vary outcomes (Seymour et al., 2000). Young males show higher prevalence, complicating universal models. 309 citations underscore need for predictive tools.

Effective Clinical Management

Surgical excision recurs without addressing causes; adjuncts like chlorhexidine show limited efficacy (James et al., 2017). Integration with periodontal therapy remains suboptimal. Foundational reviews call for targeted pharmacotherapies (Hassell and Hefti, 1991).

Essential Papers

Oral potentially malignant disorders: A consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer

Saman Warnakulasuriya, Omar Kujan, José M. Aguirre‐Urizar et al. · 2020 · Oral Diseases · 1.0K citations

Abstract Oral potentially malignant disorders (OPMDs) are associated with an increased risk of occurrence of cancers of the lip or oral cavity. This paper presents an updated report on the nomencla...

Matrix metalloproteinases: Contribution to pathogenesis, diagnosis and treatment of periodontal inflammation

Timo Sorsa, Leo Tjäderhane, Yrjö T. Konttinen et al. · 2006 · Annals of Medicine · 658 citations

Matrix metalloproteinases (MMPs) form a family of enzymes that mediate multiple functions both in the tissue destruction and immune responses related to periodontal inflammation. The expression and...

Chlorhexidine mouthrinse as an adjunctive treatment for gingival health

P. M. C. James, Helen V Worthington, C. J. Parnell et al. · 2017 · Cochrane Database of Systematic Reviews · 544 citations

There is high-quality evidence from studies that reported the Löe and Silness Gingival Index of a reduction in gingivitis in individuals with mild gingival inflammation on average (mean score of 1 ...

The Treatment of Impaired Wound Healing in Diabetes: Looking among Old Drugs

Simona Federica Spampinato, Grazia Ilaria Caruso, Rocco De Pasquale et al. · 2020 · Pharmaceuticals · 414 citations

Chronic wounds often occur in patients with diabetes mellitus due to the impairment of wound healing. This has negative consequences for both the patient and the medical system and considering the ...

The pathogenesis of drug‐induced gingival overgrowth

R. A. Seymour, John M. Thomason, Janice Ellis · 1996 · Journal Of Clinical Periodontology · 400 citations

Abstract Gingival overgrowth is a well‐documented unwanted effect, associated with phenytoin, cyclosporin. and the calcium channel blockers. The pathogenesis of drug‐induced gingival overgrowth is ...

Dental plaque–induced gingival conditions

Shinya Murakami, Brian L. Mealey, Angelo Mariotti et al. · 2018 · Journal of Periodontology · 398 citations

Abstract Objective This review proposes revisions to the current classification system for gingival diseases and provides a rationale for how it differs from the 1999 classification system. Importa...

Dental Plaque‐Induced Gingival Diseases

Angelo Mariotti · 1999 · Annals of Periodontology · 328 citations

Gingival diseases are a diverse family of complex and distinct pathological entities found within the gingiva that are the result of a variety of etiologies. There are several clinical characterist...

Reading Guide

Foundational Papers

Start with Seymour et al. (1996, 400 citations) for pathogenesis overview, Hassell and Hefti (1991, 286 citations) for clinical context, then Seymour et al. (2000, 309 citations) for risks—these establish core mechanisms cited 1,000+ times.

Recent Advances

Study Sorsa et al. (2006, 658 citations) for MMP roles; Murakami et al. (2018, 398/347 citations) for gingival classifications integrating DIGO; Warnakulasuriya et al. (2020, 1029 citations) for malignant potential links.

Core Methods

Core techniques: gingival indices (Löe-Silness), MMP zymography (Sorsa et al., 2006), epidemiological risk modeling (Seymour et al., 2000), fibroblast proliferation assays (Seymour et al., 1996).

How PapersFlow Helps You Research Drug-Induced Gingival Overgrowth

Discover & Search

Research Agent uses searchPapers and citationGraph to map Seymour et al. (1996, 400 citations) as central node, revealing clusters on cyclosporin risks; exaSearch uncovers 250M+ OpenAlex papers beyond lists; findSimilarPapers links to Sorsa et al. (2006) MMP pathways.

Analyze & Verify

Analysis Agent applies readPaperContent to extract fibroblast data from Seymour et al. (2000), then verifyResponse with CoVe for risk factor accuracy; runPythonAnalysis statistically verifies prevalence correlations across 10 papers using pandas; GRADE grading scores evidence from RCTs in James et al. (2017).

Synthesize & Write

Synthesis Agent detects gaps in pathogenesis unification via contradiction flagging between Hassell (1991) and Seymour (1996); Writing Agent uses latexEditText, latexSyncCitations for DIGO review manuscripts, latexCompile for publication-ready PDFs, exportMermaid for pathogenesis diagrams.

Use Cases

"Correlate phenytoin dosage with gingival overgrowth prevalence in 10 studies"

Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas meta-analysis on dosages vs. indices) → CSV export of regression stats and p-values.

"Draft LaTeX review on DIGO risk factors citing Seymour papers"

Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations (10 papers) → latexCompile → peer-reviewed PDF with figures.

"Find code for MMP expression models in gingival overgrowth papers"

Research Agent → paperExtractUrls (Sorsa 2006) → Code Discovery → paperFindGithubRepo → githubRepoInspect → runnable Python scripts for enzyme simulations.

Automated Workflows

Deep Research workflow conducts systematic review of 50+ DIGO papers via searchPapers → citationGraph → GRADE synthesis, outputting structured report on pathogenesis evolution. DeepScan applies 7-step CoVe analysis to verify risk factors from Seymour et al. (2000), with Python checkpoint stats. Theorizer generates hypotheses linking MMPs (Sorsa et al., 2006) to DIGO fibroblast models.

Try Doxa for Drug-Induced Gingival Overgrowth Research

Frequently Asked Questions

What defines Drug-Induced Gingival Overgrowth?

DIGO is excessive gingival tissue growth induced by phenytoin, cyclosporin A, or calcium channel blockers, primarily affecting interdental papillae in medicated patients (Seymour et al., 1996).

What are main methods to study DIGO?

Methods include clinical indices (plaque/gingival scores), fibroblast culture assays, and risk factor epidemiology; MMP activity assays link to pathogenesis (Sorsa et al., 2006; Seymour et al., 2000).

What are key papers on DIGO?

Seymour et al. (1996, 400 citations) on pathogenesis; Seymour et al. (2000, 309 citations) on risks; Hassell and Hefti (1991, 286 citations) on clinical issues.

What open problems exist in DIGO research?

Unifying pathogenesis hypothesis absent; genetic predictors underdeveloped; recurrence post-surgery unaddressed despite adjuncts like chlorhexidine (James et al., 2017).